Diabetic Retinopathy: Stages, Symptoms, Treatment, and Prevention

Medical Disclaimer: This article is for informational purposes only and does not constitute medical advice. Regular dilated eye exams with a qualified eye care professional are essential for anyone with type 2 diabetes.

Diabetic retinopathy is the leading cause of new blindness in working-age adults in the United States — yet it is largely preventable. The key is understanding what it is, catching it early, and controlling the underlying risk factors that drive it.

What Is Diabetic Retinopathy?

Diabetic retinopathy is damage to the blood vessels in the retina — the light-sensitive tissue at the back of the eye — caused by prolonged elevated blood sugar. High glucose weakens and distorts the tiny blood vessels of the retina, causing them to leak fluid, bleed, or grow abnormally. Over time, this damages the retinal tissue needed for clear vision.

According to the National Eye Institute (NEI), approximately one in three people with diabetes over age 40 has some degree of diabetic retinopathy. It often has no symptoms in its early stages — which is why routine screening is critical.

What Are the Stages of Diabetic Retinopathy?

Stage 1: Mild Non-Proliferative Diabetic Retinopathy (NPDR)

Small areas of balloon-like swelling (microaneurysms) form in the retinal blood vessels. There are usually no vision symptoms at this stage. Blood sugar control at this stage can halt or reverse progression.

Stage 2: Moderate Non-Proliferative Diabetic Retinopathy

More blood vessels become blocked, preventing adequate blood flow to portions of the retina. The retina signals distress by releasing growth factors. Some patients may notice mild visual changes.

Stage 3: Severe Non-Proliferative Diabetic Retinopathy

Larger areas of the retina lose blood supply. The retina releases vascular endothelial growth factor (VEGF), signaling the body to grow new blood vessels. Without treatment, a significant proportion of patients progress to the proliferative stage within a year.

Stage 4: Proliferative Diabetic Retinopathy (PDR)

Abnormal new blood vessels grow on the surface of the retina and into the vitreous gel. These new vessels are fragile and prone to bleeding — causing floaters, sudden vision loss, and potentially retinal detachment. This is the advanced, vision-threatening stage. PDR affects approximately 15% of people with type 2 diabetes with long disease duration.

What Is Diabetic Macular Edema?

Diabetic macular edema (DME) is a complication that can occur at any stage of retinopathy. It happens when leaking blood vessels cause fluid to accumulate in the macula — the central part of the retina responsible for sharp, detailed vision. DME is the most common cause of vision loss in people with diabetic retinopathy and causes blurring of central vision.

What Are the Symptoms of Diabetic Retinopathy?

The danger of diabetic retinopathy is that it often causes no symptoms until significant damage has occurred. When symptoms do appear, they may include:

  • Floaters — spots, strings, or dark shapes drifting across vision
  • Blurred or fluctuating vision
  • Dark or empty areas in vision (scotomas)
  • Difficulty with color perception
  • Sudden vision loss (in advanced stages with vitreous hemorrhage or retinal detachment)

Any sudden change in vision in a person with diabetes is a medical emergency — seek same-day evaluation from an ophthalmologist.

What Causes Diabetic Retinopathy to Progress?

The primary driver is duration of diabetes combined with poor blood sugar control. The longer blood sugar remains elevated, the greater the cumulative vascular damage. Key risk factors for progression include:

  • High HbA1c — each 1% increase in A1c is associated with significantly increased retinopathy risk
  • High blood pressure — hypertension accelerates retinal blood vessel damage independently of glucose
  • High cholesterol — lipid deposits in retinal vessels (hard exudates) worsen prognosis
  • Kidney disease — diabetic nephropathy and retinopathy share common vascular pathways and often progress together
  • Pregnancy in women with pre-existing diabetes — hormonal changes accelerate retinopathy progression
  • Smoking — worsens vascular damage across all diabetes complications
  • Duration of diabetes — risk rises sharply after 10–15 years of disease

How Is Diabetic Retinopathy Diagnosed?

Diagnosis requires a dilated eye exam by an ophthalmologist or optometrist. Dilating eye drops widen the pupil, allowing the provider to examine the entire retina. Additional diagnostic tools include:

  • Optical coherence tomography (OCT): High-resolution cross-sectional imaging of the retina — the standard for detecting and monitoring macular edema
  • Fundus photography: Photographs of the retina used to document and track changes over time; increasingly used in teleretinal screening programs
  • Fluorescein angiography: Dye injected into the bloodstream highlights retinal blood vessels, revealing areas of leakage, blockage, or abnormal growth
  • AI-assisted screening: FDA-approved AI systems (such as IDx-DR) can screen for diabetic retinopathy from retinal photographs in primary care settings without a specialist

The ADA recommends a dilated eye exam at diagnosis for people with type 2 diabetes (since they may have had undetected diabetes for years), then annually thereafter. If retinopathy is present and stable, exams every 1–2 years may suffice; active retinopathy requires more frequent monitoring.

How Is Diabetic Retinopathy Treated?

Blood Sugar and Blood Pressure Control

For mild to moderate NPDR, the most effective treatment is aggressive management of the underlying risk factors. The landmark ACCORD Eye Study demonstrated that intensive glycemic control reduced the risk of diabetic retinopathy progression by 33%.

Anti-VEGF Injections

Anti-VEGF drugs (ranibizumab, aflibercept, bevacizumab) injected directly into the vitreous of the eye block the growth factor driving abnormal blood vessel formation. They are the standard of care for diabetic macular edema and are increasingly used for proliferative retinopathy, often replacing laser therapy as first-line treatment.

Laser Photocoagulation

Laser treatment seals leaking blood vessels (focal/grid laser for DME) or destroys abnormal new vessels and peripheral retinal tissue to reduce the eye’s demand for oxygen (panretinal photocoagulation for PDR). This treatment does not restore lost vision but prevents further deterioration.

Vitrectomy

Surgical removal of the vitreous gel is performed for advanced PDR with vitreous hemorrhage that does not clear spontaneously, or for traction retinal detachment. Recovery is prolonged but can preserve or restore vision in appropriate cases.

How Can Diabetic Retinopathy Be Prevented?

Prevention centers on the same core strategies that prevent all diabetes complications:

  • Control blood sugar: Keeping HbA1c below 7.0% dramatically reduces retinopathy risk and progression. Even patients who already have mild retinopathy can slow progression with improved control.
  • Control blood pressure: Target below 130/80 mmHg. ACE inhibitors and ARBs may offer specific retinal protective effects beyond blood pressure reduction.
  • Control cholesterol: Fenofibrate (a lipid-lowering medication) has shown specific retinal benefit in clinical trials, reducing the need for laser treatment — an effect distinct from its lipid effects.
  • Don’t smoke: Smoking worsens vascular damage throughout the body including the retina.
  • Attend all scheduled eye exams: Most vision loss from diabetic retinopathy is preventable when caught early. Annual dilated exams are the single most important screening action.

Key Takeaways

  • Diabetic retinopathy is the leading cause of blindness in working-age adults — but it is largely preventable with good diabetes management and regular screening
  • It has no symptoms in early stages; annual dilated eye exams are the only way to detect it before vision is affected
  • The primary drivers are poor blood sugar control, high blood pressure, and disease duration
  • Treatment ranges from tighter glucose and BP control (early stage) to anti-VEGF injections and laser therapy (advanced stages)
  • Any sudden change in vision in a person with diabetes requires immediate evaluation

Related Reading

keithsurveys2@gmail.com
Keith Williams is the creator of ABCs of A1C, an educational resource focused on blood sugar control and Type 2 diabetes awareness. His work focuses on translating complex metabolic and diabetes research into practical lifestyle information that readers can understand and apply in daily life.

Leave a Comment

Your email address will not be published. Required fields are marked *